Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities



Rating:

Share or cite this content

Citations should be made in the following way:
M. Steindor (Essen, Germany), F. Stehling (Essen, Germany), M. Olivier (Essen, Germany), J. Kehrmann (Essen, Germany), M. Diricks (Borstel, Germany), F. Maurer (Borstel, Germany), P. Horn (Essen, Germany), S. Straßburg (Essen, Germany), M. Welsner (Essen, Germany), S. Sutharsan (Essen, Germany), M. Lindemann (Essen, Germany). Species-specific Interferon-Gamma Release Assay for the diagnosis of Mycobacterium abscessus complex infection in Cystic Fibrosis patients.. 1017

Member's Comments

No comment yet.

Related content which might interest you: Mycobacterium tuberculosis Cording in Alveolar Macrophages of Tuberculosis Patients and Mycobacterial Virulence Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Prevalence of Latent Infection with Mycobacterium Tuberculosis in Interstitial Lung Diseases Using Interferon Gamma Release Assay Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Mycobacterial Lung Disease in Patients With Mycobacterium avium Complex Lung Disease Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Do CT findings of Mycobacterium abscessus infection in patients with Cystic Fibrosis predict outcome? Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Treatment outcomes of macrolide-resistant mycobacterium avium complex lung disease Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis Source: Eur Respir J 2015; 46: 707-716 Year: 2015 Characteristics of patients with isolation of mycobacterium xenopi Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Clnico-microbiological analysis of mycobacaterium abscessus complex in Japan Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Incidence and outcomes of Mycobacterium abscesssus infections in non-Cystic Fibrosis patients Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Pulmonary mycobacterium xenopi infection in Japan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Tuberculosis Antigen Stimulated CXCR3 Ligand Assay for the Diagnosis of Tuberculous Lymphadenitis Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Evaluation of PCR primers to detect mycobacterium tuberculosis complex in feces Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Nontuberculous mycobacterial lung disease caused by Mycobacterium parascrofulaceum in an immunocompetent patient Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Validation of the Nontuberculous Mycobacteria (NTM) Module in NTM Lung Disease Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Diagnostic utility of Primary  Line Probe Assay in Extrapulmonary Tuberculosis Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Development of a prognostic scoring system for Mycobacterium avium complex lung disease Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Rapid Detection of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis Strains Using Allele-specific PCR Source: International Congress 2017 – MDRTB: detection and management Year: 2017 Patterns of isolation and drug sensitivity in non-tuberculous mycobacteria Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015